Document is current
Any future updates will be listed below
-
Authors
Franco, Israel
- License Information
-
More Information
Article History
Accepted: 16 December 2023
First Online: 6 February 2024
Declarations
:
: The author was a consultant for Allergan and participated in the conception and development of the clinical trial as well as an investigator in the clinical trial of onabotulinum toxin A in children.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
